Zobrazeno 1 - 3
of 3
pro vyhledávání: '"K. B. Malme"'
Autor:
H. Midgard, A. K. Finbråten, K. B. Malme, R. M. Berg-Pedersen, L. Tanum, I. C. Olsen, R. Bjørnestad, O. Dalgard
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-17 (2020)
Abstract Background Scaled-up direct-acting antiviral (DAA) treatment of hepatitis C virus (HCV) infection among people who inject drugs (PWID) is crucial to reach the World Health Organization HCV elimination targets within 2030. One of the critical
Externí odkaz:
https://doaj.org/article/93611497bf6147bcad0ad8af4b22f3af
Autor:
A. K. Finbråten, Håvard Midgard, Olav Dalgard, K. B. Malme, L. Tanum, R. Bjørnestad, R. M. Berg-Pedersen, Inge C. Olsen
Publikováno v:
Trials
Trials, Vol 21, Iss 1, Pp 1-17 (2020)
Trials, Vol 21, Iss 1, Pp 1-17 (2020)
Background Scaled-up direct-acting antiviral (DAA) treatment of hepatitis C virus (HCV) infection among people who inject drugs (PWID) is crucial to reach the World Health Organization HCV elimination targets within 2030. One of the critical obstacle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca35bb6041ab293d28971d202ef46fe1
http://hdl.handle.net/10852/76980
http://hdl.handle.net/10852/76980
Autor:
Midgard, H.1,2 (AUTHOR) havardmi@gmail.com, Finbråten, A. K.3,4 (AUTHOR), Malme, K. B.1 (AUTHOR), Berg-Pedersen, R. M.5 (AUTHOR), Tanum, L.6,7 (AUTHOR), Olsen, I. C.8 (AUTHOR), Bjørnestad, R.9 (AUTHOR), Dalgard, O.1,10 (AUTHOR)
Publikováno v:
Trials. 6/15/2020, Vol. 21 Issue 1, p1-17. 17p. 3 Diagrams, 1 Chart.